Home›Albuterol

Albuterol

Also known as: Albuterol

Route: Oral

28 interactions on record

Albuterol has 28 known drug interactions based on U.S. FDA drug labeling data. 6 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Acidifying Agents, Atomoxetine, Insulin Glargine. Patients taking Albuterol should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total: 28
Major: 6
Moderate: 21

Major (6)

Albuterol + Acidifying Agents— Concomitant use with albuterol tablets may lead to deleterious cardiovascular effects. Combined use not recommended on r…
Albuterol + Atomoxetine— Beta-2 agonist; action on cardiovascular system can be potentiated by atomoxetine, resulting in increases in heart rate …
Albuterol + Insulin Glargine— May decrease blood glucose lowering effect of LANTUS. Dosage increases and increased glucose monitoring may be required.
Albuterol + Methacholine Chloride— Inhibits airway response to methacholine chloride; hold for 6 hours before testing.
Albuterol + Monoamine Oxidase Inhibitors (Maois)— Albuterol should be administered with extreme caution; the action of albuterol on the vascular system may be potentiated…
Albuterol + Nonselective Beta-Adrenergic Antagonists— Beta-blockers block the pulmonary effect of albuterol and may produce severe bronchospasm in asthmatic patients. Patient…

Moderate (21)

Albuterol + Andthiazide— Non-potassium-sparing thiazide diuretics can cause ECG changes and hypokalemia that may be worsened by albuterol, especi…
Albuterol + Atomoxetine Hydrochloride— Beta-2 agonist; action on cardiovascular system can be potentiated, resulting in increases in heart rate and blood press…
Albuterol + Digoxin— Decreases digoxin concentrations. Requires monitoring and dose adjustment.
Albuterol + Glimepiride— Sympathomimetic that may reduce glucose-lowering effect of glimepiride, leading to worsening glycemic control.
Albuterol + Glipizide— May reduce glucose-lowering effect of glipizide, leading to worsening glycemic control; monitor closely.
Albuterol + Insulin Aspart Injection— Sympathomimetic agent that may decrease the blood glucose lowering effect. Dose adjustment and increased glucose monitor…
Albuterol + Insulin Aspart-Szjj— May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.
Albuterol + Insulin Degludec— Sympathomimetic agent that may decrease blood glucose lowering effect. Dosage increases and increased glucose monitoring…
Albuterol + Insulin Degludec And Liraglutide— Sympathomimetic agent that may decrease blood glucose-lowering effect; dosage increases and increased glucose monitoring…
Albuterol + Insulin Detemir— May decrease blood glucose lowering effect of insulin detemir. Dosage increases and increased glucose monitoring may be …
Albuterol + Insulin Glargine And Lixisenatide— Sympathomimetic agent that may decrease the blood glucose lowering effect. Dose increases and increased glucose monitori…
Albuterol + Insulin Glargine-Aglr— Sympathomimetic agent that may decrease blood glucose lowering effect. Dosage increases and increased glucose monitoring…
Albuterol + Insulin Glargine-Yfgn— Sympathomimetic agent that may decrease blood glucose lowering effect. Dosage increases and increased glucose monitoring…
Albuterol + Insulin Glulisine— Sympathomimetic agent may decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may b…
Albuterol + Insulin Human— Sympathomimetic agent that may decrease blood glucose lowering effect; dose adjustment and glucose monitoring may be req…
Albuterol + Insulin Icodec-Abae— May decrease blood glucose lowering effect of Awiqli. Dose increases and increased glucose monitoring may be required.
Albuterol + Insulin Lispro— Sympathomimetic agent that may decrease blood glucose lowering effect; dose adjustment and increased glucose monitoring …
Albuterol + Insulin Lispro-Aabc— Sympathomimetic agent that may decrease blood glucose lowering effect. Dose increases and increased glucose monitoring m…
Albuterol + Ipratropium Bromide Inhalation— Concomitant use evaluated; formal studies exist but safety and effectiveness interaction not fully characterized with ot…
Albuterol + Loop Diuretics— Non-potassium-sparing loop diuretics can cause ECG changes and hypokalemia that may be worsened by albuterol, especially…
Albuterol + Sotalol Hydrochloride— Beta-agonist; may require increased dosages when used concomitantly with sotalol.

Albuterol + Acidifying Agents⚠️Major

Concomitant use with albuterol tablets may lead to deleterious cardiovascular effects. Combined use not recommended on routine basis.

Albuterol + Atomoxetine⚠️Major

Beta-2 agonist; action on cardiovascular system can be potentiated by atomoxetine, resulting in increases in heart rate and blood pressure, particularly with systemic administration.

Albuterol + Insulin Glargine⚠️Major

May decrease blood glucose lowering effect of LANTUS. Dosage increases and increased glucose monitoring may be required.

Albuterol + Methacholine Chloride⚠️Major

Inhibits airway response to methacholine chloride; hold for 6 hours before testing.

Albuterol + Monoamine Oxidase Inhibitors (Maois)⚠️Major

Albuterol should be administered with extreme caution; the action of albuterol on the vascular system may be potentiated.

Albuterol + Nonselective Beta-Adrenergic Antagonists⚠️Major

Beta-blockers block the pulmonary effect of albuterol and may produce severe bronchospasm in asthmatic patients. Patients with asthma should not normally be treated with beta-blockers.

Albuterol + Andthiazide🟡Moderate

Non-potassium-sparing thiazide diuretics can cause ECG changes and hypokalemia that may be worsened by albuterol, especially at higher doses. Caution advised in co-administration.

Albuterol + Atomoxetine Hydrochloride🟡Moderate

Beta-2 agonist; action on cardiovascular system can be potentiated, resulting in increases in heart rate and blood pressure, particularly with systemic administration.

Albuterol + Digoxin🟡Moderate

Decreases digoxin concentrations. Requires monitoring and dose adjustment.

Albuterol + Glimepiride🟡Moderate

Sympathomimetic that may reduce glucose-lowering effect of glimepiride, leading to worsening glycemic control.

Albuterol + Glipizide🟡Moderate

May reduce glucose-lowering effect of glipizide, leading to worsening glycemic control; monitor closely.

Albuterol + Insulin Aspart Injection🟡Moderate

Sympathomimetic agent that may decrease the blood glucose lowering effect. Dose adjustment and increased glucose monitoring required.

Albuterol + Insulin Aspart-Szjj🟡Moderate

May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.

Albuterol + Insulin Degludec🟡Moderate

Sympathomimetic agent that may decrease blood glucose lowering effect. Dosage increases and increased glucose monitoring may be required.

Albuterol + Insulin Degludec And Liraglutide🟡Moderate

Sympathomimetic agent that may decrease blood glucose-lowering effect; dosage increases and increased glucose monitoring may be required.

Albuterol + Insulin Detemir🟡Moderate

May decrease blood glucose lowering effect of insulin detemir. Dosage increases and increased glucose monitoring may be required.

Albuterol + Insulin Glargine And Lixisenatide🟡Moderate

Sympathomimetic agent that may decrease the blood glucose lowering effect. Dose increases and increased glucose monitoring may be required.

Albuterol + Insulin Glargine-Aglr🟡Moderate

Sympathomimetic agent that may decrease blood glucose lowering effect. Dosage increases and increased glucose monitoring may be required.

Albuterol + Insulin Glargine-Yfgn🟡Moderate

Sympathomimetic agent that may decrease blood glucose lowering effect. Dosage increases and increased glucose monitoring may be required.

Albuterol + Insulin Glulisine🟡Moderate

Sympathomimetic agent may decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.

Albuterol + Insulin Human🟡Moderate

Sympathomimetic agent that may decrease blood glucose lowering effect; dose adjustment and glucose monitoring may be required.

Albuterol + Insulin Icodec-Abae🟡Moderate

May decrease blood glucose lowering effect of Awiqli. Dose increases and increased glucose monitoring may be required.

Albuterol + Insulin Lispro🟡Moderate

Sympathomimetic agent that may decrease blood glucose lowering effect; dose adjustment and increased glucose monitoring required.

Albuterol + Insulin Lispro-Aabc🟡Moderate

Sympathomimetic agent that may decrease blood glucose lowering effect. Dose increases and increased glucose monitoring may be required.

Albuterol + Ipratropium Bromide Inhalation🟡Moderate

Concomitant use evaluated; formal studies exist but safety and effectiveness interaction not fully characterized with other sympathomimetic bronchodilators.

Albuterol + Loop Diuretics🟡Moderate

Non-potassium-sparing loop diuretics can cause ECG changes and hypokalemia that may be worsened by albuterol, especially at higher doses. Caution advised in co-administration.

Albuterol + Sotalol Hydrochloride🟡Moderate

Beta-agonist; may require increased dosages when used concomitantly with sotalol.

Albuterol + Ipratroprium Bromideℹ️Unknown

Concomitant use has been formally studied with respect to safety and effectiveness in ATROVENT HFA.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.